Terazosin Discontinued in New Zealand

USANZ has been informed by Pharmac that terazosin will be discontinued in New Zealand.

• PHARMAC has been unsuccessful in sourcing a long-term supply of terazosin 2 mg and 5 mg tablets.
• Prescribers will need to transition patients to an alternative funded agent.
• PHARMAC have sourced a limited supply of an unapproved brand of terazosin, Teva Terazosin (supplied under section 29 of the Medicines Act 1981). 
• Teva Terazosin will be available in New Zealand early October 2020 and will assist in the transition to alternative funded agents.

For more information on the discontinuation, please refer to the PHARMAC website or email PHARMAC.